To evaluate the efficacy of haritaki lepa in the management of acne post-inflammatory hyperpigmentation

"A randomized controlled clinical study to evaluate the efficacy of haritaki lepa in the management of acne post-inflammatory hyperpigmentation"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043361

Enrollment

Registered

2022-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L810- Postinflammatory hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: subjects diagnosed with acne post-inflammatory hyperpigmentation. subjects of age group between 20-40years will be included irrespective of their gender, religion and socio-economic status. subjects who are willing to participate in the study will be included

Exclusion criteria

Exclusion criteria: subjects with PIH due to mechanical trauma will be excluded. subjects taking photosensitizing drug will be excluded. subjects with melasma will be excluded. subjects who have undergone chemical peeling of skin will be excluded. subjects who have photosensitivity of skin due to systemic diseases, side effects of any cosmetic products will be excluded

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Haritaki Lepa in Acne Post inflammatory hyperpigmentationTimepoint: Post inflammatory hyperpigmentation severity scale assessment will be done- pre study assessment-0th day 1st assessment - 7th day 2nd assessment-14th day 1st follow up -21st day	—

Secondary

Measure	Time frame
To re-evaluate the effect of conventional topical cream (mederma) in Acne Post inflammatory hyperpigmentation. to compare the efficacy of haritaki lepa with conventional topical cream (mederma) in Acne Post inflammatory hyperpigmentation.Timepoint: Post inflammatory hyperpigmentation severity scale assessment will be done- pre study assessment-0th day 1st assessment - 7th day 2nd assessment-14th day 1st follow up -21st day	—

Measure

Time frame

To re-evaluate the effect of conventional topical cream (mederma) in Acne Post inflammatory hyperpigmentation. to compare the efficacy of haritaki lepa with conventional topical cream (mederma) in Acne Post inflammatory hyperpigmentation.Timepoint: Post inflammatory hyperpigmentation severity scale assessment will be done- pre study assessment-0th day 1st assessment - 7th day 2nd assessment-14th day 1st follow up -21st day

—

Countries

India

Contacts

Public ContactDr Yashaswini T

RGUHS University

sajithak96@gmail.com7760987722

Outcome results